Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 579.00% | 85.41% | 453.95% | 60.66% |
| Total Other Revenue | 48.52% | 53.61% | 42.53% | 97.67% | 35.11% |
| Total Revenue | 48.52% | 55.56% | 42.89% | 99.71% | 34.66% |
| Cost of Revenue | 50.56% | 56.51% | 39.16% | 111.95% | 39.74% |
| Gross Profit | 33.41% | 48.25% | 88.28% | 32.25% | 6.14% |
| SG&A Expenses | 6.75% | 43.93% | 46.63% | 37.79% | 41.09% |
| Depreciation & Amortization | 125.23% | 126.00% | 101.83% | 114.69% | -7.22% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.87% | 56.42% | 40.40% | 105.77% | 39.08% |
| Operating Income | 68.74% | 32.37% | 2,343.75% | 3.82% | -32.35% |
| Income Before Tax | 61.72% | 105.22% | 496.09% | -78.85% | -47.25% |
| Income Tax Expenses | 32.52% | 94.44% | -83.95% | -41.34% | -34.11% |
| Earnings from Continuing Operations | 80.62% | 111.08% | 184.38% | -94.33% | -53.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 262.30% | 177.07% | -168.16% | 75.61% | 70.58% |
| Net Income | 109.48% | 115.72% | 186.30% | -97.68% | -50.85% |
| EBIT | 68.74% | 32.37% | 2,343.75% | 3.82% | -32.35% |
| EBITDA | 83.06% | 54.61% | 284.31% | 26.39% | -27.37% |
| EPS Basic | 109.76% | 113.98% | 181.27% | -97.75% | -52.41% |
| Normalized Basic EPS | 58.08% | 78.86% | 251.67% | -33.33% | -45.70% |
| EPS Diluted | 110.53% | 109.99% | 181.27% | -97.70% | -52.50% |
| Normalized Diluted EPS | 56.87% | 79.55% | 250.83% | -32.96% | -45.58% |
| Average Basic Shares Outstanding | -0.15% | 0.79% | 6.24% | 3.21% | 3.30% |
| Average Diluted Shares Outstanding | 0.62% | 0.42% | 6.88% | 2.59% | 3.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.94% | -0.99% | -- | -- | -- |